✦ LIBER ✦

Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998–2003

✍ Scribed by Eyasu H. Teshale; Debra Hanson; Brendan Flannery; Christina Phares; Mitchell Wolfe; Anne Schuchat; Patrick Sullivan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

23–valent pneumococcal polysaccharide va

✍ N French; J Nakiyingi; LM Carpenter; E Lugada; C Watera; K Moi; M Moore; D Antve 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 103 KB

Clinical effectiveness of 23-valent pneu

✍ Angel Vila-Corcoles; Elisabet Salsench; Teresa Rodriguez-Blanco; Olga Ochoa-Gond 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 158 KB

The effectiveness of pneumococcal polysa

✍ RH Pedersen; N Lohse; L Østergaard; OS Søgaard 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Cost-effectiveness of stockpiling 23-val

✍ Praveen Dhankhar; John D. Grabenstein; Megan A. O’Brien; Erik J. Dasbach 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Failure to vaccinate or failure of vacci

✍ S. Moberley; V. Krause; H. Cook; K. Mulholland; J. Carapetis; P. Torzillo; R. An 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 235 KB

The effect of 23-valent pneumococcal pol

✍ George V. Orthopoulos; Maria C. Theodoridou; Vasilis A. Ladis; Dimitris K. Tsous 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 134 KB